Search research articles
Contact Us
Filters
Showing results (271-280 of 283) with videos related to
Page
of 29
Sort By:
Gene
|
July 16, 2013
Biallelic nonsense mutations in the otogelin-like gene (OTOGL) in a child affected by mild to moderate hearing impairment
C Bonnet, M Louha, N Loundon, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 7, 2016
Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [<sup>11</sup>C]-( R)-PK11195 PET and MRI
J Yankam Njiwa, N Costes, C Bouillot, et al.
Revue Neurologique
|
April 8, 2017
GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study
C Bonnet, J Rusz, J Hanuška, et al.
Revue Neurologique
|
April 22, 2014
Solitary tuberculous brain lesions: 24 new cases and a review of the literature
D Psimaras, C Bonnet, A Heinzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
L de Leval, C Bonnet, C Copie-Bergman, et al.
JIMD Reports
|
January 29, 2015
Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for Rare Autosomal Recessive Nonsyndromic Intellectual Disability with No Clinical or Biochemical Metabolic Markers
S El Chehadeh, C Bonnet, P Callier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
A S Cottereau, S Becker, F Broussais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Scientific Reports
|
October 12, 2017
6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
C Delehouzé, S Leverrier-Penna, F Le Cann, et al.
Clinical Genetics
|
July 5, 2011
What can we learn from old microdeletion syndromes using array-CGH screening?
A L Mosca-Boidron, S Bouquillon, L Faivre, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 283) with videos related to
Sort By:
Page
of 29
Gene
|
July 16, 2013
Biallelic nonsense mutations in the otogelin-like gene (OTOGL) in a child affected by mild to moderate hearing impairment
C Bonnet, M Louha, N Loundon, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
July 7, 2016
Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [<sup>11</sup>C]-( R)-PK11195 PET and MRI
J Yankam Njiwa, N Costes, C Bouillot, et al.
Revue Neurologique
|
April 8, 2017
GABA spectra and remote distractor effect in progressive supranuclear palsy: A pilot study
C Bonnet, J Rusz, J Hanuška, et al.
Revue Neurologique
|
April 22, 2014
Solitary tuberculous brain lesions: 24 new cases and a review of the literature
D Psimaras, C Bonnet, A Heinzmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA study
L de Leval, C Bonnet, C Copie-Bergman, et al.
JIMD Reports
|
January 29, 2015
Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for Rare Autosomal Recessive Nonsyndromic Intellectual Disability with No Clinical or Biochemical Metabolic Markers
S El Chehadeh, C Bonnet, P Callier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)
A S Cottereau, S Becker, F Broussais, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)
N Ketterer, B Coiffier, C Thieblemont, et al.
Scientific Reports
|
October 12, 2017
6E11, a highly selective inhibitor of Receptor-Interacting Protein Kinase 1, protects cells against cold hypoxia-reoxygenation injury
C Delehouzé, S Leverrier-Penna, F Le Cann, et al.
Clinical Genetics
|
July 5, 2011
What can we learn from old microdeletion syndromes using array-CGH screening?
A L Mosca-Boidron, S Bouquillon, L Faivre, et al.
Page
of 29